Cite
HARVARD Citation
Hummers, L. et al. (2013). A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenon. Annals of the rheumatic diseases. 72 (12), pp. 1962-1967. [Online].